$UTI Cashflow Statement | Understand Stock

$UTI

$22.15 +$0.16 (0.73%) Close

$UTI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Cash flows from operating activities:
Net income
Depreciation and amortization
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Amortization of right-of-use assets for operating leases
Intangible asset impairment expense
Provision for credit losses
Stock-based compensation
Deferred income taxes
Equity in earnings of unconsolidated affiliate
Training equipment credits earned, net
Unrealized (loss) gain on interest rate swaps, net of taxes
Other losses, net
Changes in assets and liabilities:
Receivables
Notes receivable
Prepaid expenses and other current assets
Other assets
Accounts payable, accrued expenses and other current liabilities
Deferred revenue
Income tax payable/receivable
Accrued tool sets and other current liabilities
Deferred rent liability
Operating lease liability
Other liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Purchase of property and equipment
Proceeds from disposal of property and equipment
Purchase of held-to-maturity investments
Proceeds received upon maturity of investments
Proceeds from insurance policy
Cash paid for acquisitions, net of cash acquired
Return of capital contribution from unconsolidated affiliate
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from revolving credit facility
Proceeds from term loans
Debt issuance costs related to long-term debt
Proceeds from equity offering
Payment of term loans and finance leases
Payments on revolving credit facility
Payment of preferred stock cash dividend
Preferred share repurchase
Payment of payroll taxes on stock-based compensation through shares withheld
Proceeds from stock option exercises
Net cash (used in) provided by financing activities

Change in cash, cash equivalents and restricted cash
Cash and cash equivalents, beginning of period
Restricted cash, beginning of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash, cash equivalents and restricted cash, beginning of period
Cash and cash equivalents, end of period
Restricted cash, end of period
Supplemental disclosure of cash flow information:
Taxes paid
Taxes (refunded)
Income taxes paid, net of refunds
Interest paid
Training equipment obtained in exchange for services
Depreciation of training equipment obtained in exchange for services
Change in accrued capital expenditures during the period
Conversion of Series A Preferred Stock
CARES Act funds received for student emergency grants (See Note 24)
CARES Act funds disbursed for student emergency grants (See Note 24)
CARES Act funds received for institutional costs (See Note 24)
CARES Act funds for institutional costs included in Receivables, net (See Note 25)

Comments